Luuk van Hooren

2PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 20, 2023
CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma.

Luuk van Hooren, Shanna M Handgraaf, Daan J Kloosterman

|Jul 06, 2021
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma.

Luuk van Hooren, Alessandra Vaccaro, Mohanraj Ramachandran

Pageof 1

Frequent Collaborators

1 joint publications

Joey Lau

1 joint publications

Mikael C I Karlsson

1 joint publications

Magnus Essand

1 joint publications

Anna Dimberg